Last Friday, U.S. President Joe Biden officially signed an independent federal marijuana reform bill. The President signed a marijuana research bill into law, which was approved by the House of Representatives in July and authorized by the Senate last month.
The bill aims to advance research on marijuana and its potential health benefits. The law grants the U.S. Attorney General 60 days to approve specific applications or request additional information from applicants seeking to conduct research on marijuana.
The "Cannabis and Cannabinoid Research Expansion Act" is seeking to create a more efficient pathway for researchers to conduct additional studies on marijuana and its compounds.
This legislation has three components:
Firstly, to establish mechanisms for the scientific research of medical cannabis and its derivatives.
Secondly, to establish a regulatory path for commercial production of drugs containing or derived from cannabis approved by the FDA.
Thirdly, protecting doctors who discuss the risks and benefits of using marijuana and its derivatives.
According to the National Law Review, the President still opposes federal legalization of marijuana, but has advocated for some more moderate marijuana reforms, including promoting research under the Controlled Substances Act (CSA), decriminalization, and re-scheduling of marijuana.
Joe Biden has granted a large-scale pardon to Americans who were charged with federal marijuana possession offenses in October and instructed an administrative review of the marijuana scheduling. The White House recently listed these actions as one of the president's "greatest achievements.
2FIRSTS will continue to provide ongoing coverage of this issue, with updates available on the "2FIRSTSAPP". Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
